CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVB | Nuvation Bio INC | Stock-Other | 28.72% | -4.02% | -5.66% | |
| 2 | LXEO | Lexeo Therapeutics INC | Stock-Other | 28.00% | — | — | |
| 3 | REPL | Replimune Group INC | Stock-Other | 16.41% | +0.33% | -17.99% | |
| 4 | ✓ | Engene Holdings INC | Stock-Other | 7.52% | +0.90% | — | |
| 5 | ALMS | Alumis INC | Stock-Other | 6.44% | +1.03% | — | |
| 6 | MORFUSD | Morphic Holding INC | Stock-Other | 4.03% | — | — | |
| 7 | SANA | Sana Biotechnology INC | Stock-Other | 3.41% | +0.29% | — | |
| 8 | ✓ | Ikena Oncology INC | Stock-Other | 2.75% | — | — | |
| 9 | VTLUSD | Immunic INC | Stock-Other | 1.47% | — | — | |
| 10 | SYRS | Syros Pharmaceuticals INC | Stock-Other | 0.96% | — | — | |
| 11 | ✓ | Engene Holdings INC | Stock-Other | 0.28% | — | -10.92% |